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This issue is the commencement of the 250th volume of
Graefe’s Archive for Clinical and Experimental Ophthal-
mology — a proud timeline for the journal.
To predict the future, one has to acknowledge the past. Last
year the journal’s impact factor increased to 2.1. To guarantee
and continue with this success we, as Editor-in-Chiefs, need to
know how this was achieved. Who contributed to the journal?
Who downloaded our articles? Which articles were the most
cited? Perhaps most relevant to our readers, why should they
submit to our journal?
The last question is probably the easiest to answer. The
journal is going from strength to strength. The numbers
speak for themselves. Graefe’s distribution has increased
significantly, especially to institutions. The number of institu-
tions subscribing to the journal has increased from 5,350 in
2008 to 8,005 in 2010. Of course, nowadays usage of the
journal often takes the form of online download. In 2008, the
number of full-article downloads was 140,750. By 2010, this
number increased to 237,479. The purpose of publication is to
disseminate information. These figures alone should persuade
authors to consider submitting to our journal.
Access to the journal is predominantly online; it is therefore
possible to knowwho uses the journal. In terms of downloads,
the distribution is about one third from Europe and one third
from Asia-Pacific, with less than one quarter from North
America. The country with the most frequent full-article
download is USA, accounting for 19% of all downloads,
followed by Germany and China at 9% and 8% respectively.
And how do readers search for our articles? You may be
surprised that the answer is that Google and Pubmed are
now equally as popular as the academic search engine.
The number of articles being submitted has also signifi-
cantly increased. In 2008, we received 841 articles. In 2010,
this increased to 1,055. Geographically, most submissions are
from Germany at 138 articles followed by China at 128, USA
99 and Japan 87. These four countries together contributed
half of all articles published. Although Germany is clearly in
the lead in the league table of contributors, there is no doubt
that the journal is not only European but truly global, with
authors from 51 countries submitting to Graefe’s.
As open-access case-report journals have become more
popular, the trend for many international journals is to accept
fewer case reports. In 2010, we published 205 original articles,
but only 17 case reports.We, however, always welcome letters
to the editor, many of which have proven to be highly inter-
esting. In the coming 12 months, we have solicited world-
leading pathologists to prepare a series of review articles
covering different aspects of ocular pathology. We hope that
readers will find these updates useful, and that trainees will
download and study them.
The list of the top ten most cited articles in Graefe’s are
given below (Table 1). Seven of the top ten dealt with topics
related to the retina. Only four of the ten are review articles.
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The majority of the most frequently cited articles are clinical,
with only two of the ten predominantly laboratory-based
research.
After 250 years, Graefe’s Archive is now predominantly
online; it still has a retinal focus; the journal is truly global,
being contributed and accessed by all people across the
world. As editors, we are transient custodians, fully aware
of the journal’s strong tradition and our own responsibility
to ensure its continued success.
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tive Commons Attribution Noncommercial License which permits any
noncommercial use, distribution, and reproduction in any medium,
provided the original author(s) and source are credited.
Table 1 Top ten articles downloaded in 2010 (source: Coremetrics)
Title Volume Issue Year Article requests
Jan to Nov 2010
A review of clinical trials of anti-VEGF agents for diabetic retinopathy 248 7 2010 1,695
Three-dimensional ultrasound biomicroscopy, environmental and
conventional scanning electron microscopy investigations of the
human zonula ciliaris for numerical modelling of accommodation
244 7 2006 767
Verteporfin PDT for non-standard indications—a review of current
literature
248 5 2010 637
Non-arteritic anterior ischemic optic neuropathy: role of systemic
corticosteroid therapy
246 7 2008 591
A tissue-engineered approach towards retinal repair: scaffolds for cell
transplantation to the subretinal space
248 6 2010 549
A systematic review on the effect of bevacizumab in exudative
age-related macular degeneration
247 1 2009 519
Treatment of neovascular age-related macular degeneration with a
variable ranibizumab dosing regimen and one-time reduced-fluence
photodynamic therapy: the TORPEDO trial at 2 years
248 7 2010 475
Intravitreal triamcinolone acetonide versus bevacizumab therapy for
macular edema associated with branch retinal vein occlusion
248 7 2010 451
Twelve-month safety of intravitreal injections of bevacizumab
(Avastin®): results of the Pan-American Collaborative Retina Study
Group (PACORES)
246 1 2008 441
Amyloid precursor protein processing and retinal pathology in mouse
models of Alzheimer’s disease
247 9 2009 423
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